Search research articles
Contact Us
Filters
Showing results (301-310 of 413) with videos related to
Page
of 42
Sort By:
Jac-Antimicrobial Resistance
|
September 6, 2024
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced susceptibility to both agents at baseline
Ghady Haidar, Ellen G Kline, Georgios D Kitsios, et al.
Cells
|
March 13, 2024
Harnessing the Diversity of <i>Burkholderia</i> spp. Prophages for Therapeutic Potential
Hayley R Nordstrom, Marissa P Griffith, Vatsala Rangachar Srinivasa, et al.
Plos One
|
March 8, 2017
Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria
Ryan K Shields, Rohit Anand, Lloyd G Clarke, et al.
Antimicrobial Agents and Chemotherapy
|
June 15, 2016
Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species
Ghady Haidar, Ammar Alkroud, Shaoji Cheng, et al.
The Journal of Infectious Diseases
|
May 30, 2025
Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis
Yanhong Li, Madison E Stellfox, Kirsten M Evans, et al.
Antimicrobial Agents and Chemotherapy
|
April 6, 2026
Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactams
Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
Harnessing the diversity of <i>Burkholderia</i> spp. prophages for therapeutic potential
Hayley R Nordstrom, Marissa P Griffith, Vatsala Rangachar Srinivasa, et al.
Pharmacotherapy
|
May 15, 2025
Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
Wesley D Kufel, Nabil Zeineddine, Aliaa Fouad, et al.
Antimicrobial Agents and Chemotherapy
|
July 5, 2017
Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients
Ryan M Rivosecchi, Cornelius J Clancy, Ryan K Shields, et al.
The Journal of Antimicrobial Chemotherapy
|
August 29, 2022
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae
Vincent H Tam, Paul R Merlau, Cole S Hudson, et al.
Page
of 42
Search research articles
Search
Showing results (301-310 of 413) with videos related to
Sort By:
Page
of 42
Jac-Antimicrobial Resistance
|
September 6, 2024
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced susceptibility to both agents at baseline
Ghady Haidar, Ellen G Kline, Georgios D Kitsios, et al.
Cells
|
March 13, 2024
Harnessing the Diversity of <i>Burkholderia</i> spp. Prophages for Therapeutic Potential
Hayley R Nordstrom, Marissa P Griffith, Vatsala Rangachar Srinivasa, et al.
Plos One
|
March 8, 2017
Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria
Ryan K Shields, Rohit Anand, Lloyd G Clarke, et al.
Antimicrobial Agents and Chemotherapy
|
June 15, 2016
Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species
Ghady Haidar, Ammar Alkroud, Shaoji Cheng, et al.
The Journal of Infectious Diseases
|
May 30, 2025
Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis
Yanhong Li, Madison E Stellfox, Kirsten M Evans, et al.
Antimicrobial Agents and Chemotherapy
|
April 6, 2026
Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactams
Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
Harnessing the diversity of <i>Burkholderia</i> spp. prophages for therapeutic potential
Hayley R Nordstrom, Marissa P Griffith, Vatsala Rangachar Srinivasa, et al.
Pharmacotherapy
|
May 15, 2025
Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
Wesley D Kufel, Nabil Zeineddine, Aliaa Fouad, et al.
Antimicrobial Agents and Chemotherapy
|
July 5, 2017
Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients
Ryan M Rivosecchi, Cornelius J Clancy, Ryan K Shields, et al.
The Journal of Antimicrobial Chemotherapy
|
August 29, 2022
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae
Vincent H Tam, Paul R Merlau, Cole S Hudson, et al.
Page
of 42